The importance of ventricular septal morphology in the effectiveness of dual chamber pacing in hypertrophic obstructive cardiomyopathy

PACE - Pacing and Clinical Electrophysiology

Volumn 23, Issue 9, 2000, Pages 1324-1329

  Dimitrow, Pawl Petkow ^a   Grodecki, Janusz ^a,b   Bacior, Bogumila ^a,b   Dudek, Dariusz ^a   Legutko, Jacek ^a   Jaszcz, Kalina Kawecka ^b   Dubiel, Jacek S ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Dual chamber pacing; Hypertrophic cardiomyopathy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; VERAPAMIL;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL ARTICLE; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART PACING; HEART VENTRICLE SEPTUM; HEMODYNAMIC MONITORING; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; IMPLANTATION; LUNG CAPILLARY PRESSURE; M MODE ECHOCARDIOGRAPHY; MALE; RISK BENEFIT ANALYSIS; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0033661792     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2000.tb00958.x     Document Type: Article

References (24)

1. Erfahrungen mit der Schrittmacher-dauerbehandlung bei patienten mit obstruktiver Kardiomyopathie
2. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy
3. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy
4. Pacing in hypertrophic obstructive cardiomyopathy
5. Is the permanent DDD pacing beneficial for the patients with hypertrophic obstructive cardiomyopathy?
6. DDD pacing in hypertrophic cardiomyopathy: A multicenter clinical experience
7. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: A randomized, double-blind, crossover study (M.-PATHY)
8. Ventricular pre-excitation is highly effective therapy for elderly patients with obstructive hypertrophic cardiomyopathy and symptoms refractory to medication
9. Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape
10. Clinical and morphologic expression of hypertrophic cardiomyopathy in patients > 65 years of age
11. Phenotypic spectrum and patterns of left ventricular hypertrophy cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients
12. Hypertrophic cardiomyopathy. The importance of the site and extent of hypertrophy
13. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A wide angle, two dimensional echocardiographic study of 125 patients
14. Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy
15. Predictors of sudden cardiac death in hypertrophic cardiomyopathy
16. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort
17. Epidemiology of hypertrophic cardiomyopathy revisited in an unselected patient population: Reassessment of the age at which cardiovascular-related death occurs
18. Infective endocarditis in hypertrophic cardiomyopathy: Prevalence, incidence, and indications for antibiotic prophylaxis
19. Nonsurgical myocardial reduction for hypertrophic obstructive cardiomyopathy
20. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy
21. Improvement in exercise capacity and exercise blood pressure response after transcoronary alcohol ablation therapy of septal hypertrophy in hypertrophic cardiomyopathy
22. A new treatment for hypertrophic cardiomyopathy?
23. Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms
24. Regional wall motion during pacing for hypertrophic obstructive cardiomyopathy